Showing results (1-10 of 216) with videos related to
Sort By:
Pageof 22
Annual Review of Pharmacology and Toxicology|October 2, 2020
Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical SettingsWan-Chun Chang, Reo Tanoshima, Colin J D Ross, et al.Basic & Clinical Pharmacology & Toxicology|April 26, 2021
Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapyCatrina M Loucks, Kevin Yan, Reo Tanoshima, et al.Therapeutic Drug Monitoring|September 19, 2023
Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 UpdateErika N Scott, Akshaya A Joseph, Angie Dhanda, et al.Journal of Clinical Pharmacology|November 20, 2018
Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety DatabaseReo Tanoshima, Amna Khan, Agnieszka K Biala, et al.Frontiers in Genetics|March 6, 2015
Use of pharmacogenomics in pediatric renal transplant recipientsMara Medeiros, Gilberto Castañeda-Hernández, Colin J D Ross, et al.Therapeutic Drug Monitoring|September 12, 2024
Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping ReviewAngela Wu, Edward J Raack, Colin J D Ross, et al.Therapeutic Drug Monitoring|February 2, 2023
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced CardiotoxicityAngela Siemens, Shahrad Rod Rassekh, Colin J D Ross, et al.Expert Opinion on Drug Metabolism & Toxicology|June 9, 2020
An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effectsWan-Chun Chang, Shuen-Iu Hung, Bruce C Carleton, et al.Current Opinion in Pediatrics|August 16, 2020
Prevention of adverse drug effects: a pharmacogenomic approachErika N Scott, Jafar S Hasbullah, Bruce C Carleton, et al.Paediatric Drugs|March 27, 2013
Cancer pharmacogenomics in children: research initiatives and progress to dateShahrad Rod Rassekh, Colin J D Ross, Bruce C Carleton, et al.Pageof 22